Phase II study of paclitaxel, tegafur/uracil and folinic acid as first line treatment in metastatic or recurrent head and neck squamous cell carcinomas

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5581-5581
Author(s):  
A. Berrocal ◽  
M. Pastor ◽  
C. Caballero ◽  
A. Segura ◽  
S. Garcera ◽  
...  
Keyword(s):  
Head And Neck ◽  
Folinic Acid ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Squamous Cell Carcinomas ◽  
Line Treatment ◽  
First Line ◽  
Recurrent Head ◽  
First Line Treatment

Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma

Cancer ◽  
2016 ◽  
Vol 122 (15) ◽  
pp. 2350-2355 ◽  
Author(s):  
Jared M. Weiss ◽  
Stephen Bagley ◽  
Wei-Ting Hwang ◽  
Joshua Bauml ◽  
Juneko Grilley Olson ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Line Treatment ◽  
First Line ◽  
Recurrent Head ◽  
First Line Treatment

scholarly journals Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

2019 ◽  
Vol 10 (9) ◽  
pp. 1764-1769
Author(s):  
Hirokazu Taniguchi ◽  
Hiroyuki Yamaguchi ◽  
Yosuke Dotsu ◽  
Midori Shimada ◽  
Hiroshi Gyotoku ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document